Prognostic Biomarkers of Salvage Chemotherapy Following Nivolumab Treatment for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma

Recent studies have suggested the benefit of salvage chemotherapy (SCT) after immune checkpoint inhibitor (ICI) treatment for recurrent and metastatic head and neck squamous cell carcinoma (R/M HNSCC). We retrospectively examined the outcome of SCT and the usefulness of the serum C-reactive protein...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Wakasaki, Takahiro, Yasumatsu, Ryuji, Masuda, Muneyuki, Takeuchi, Toranoshin, Manako, Tomomi, Matsuo, Mioko, Jiromaru, Rina, Uchi, Ryutaro, Komune, Noritaka, Noda, Teppei, Nakagawa, Takashi
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7463840/
https://ncbi.nlm.nih.gov/pubmed/32824226
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12082299
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados